Found 35 matching trials
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
PHASE1This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study d...
Location
Honor Health (GIST, mastocytosis, other solid tumors)
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
PHASE2This is a multi-part, randomized, double-blind, placebo-controlled Phase 2 ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Are Mast Cells Involved in Autoinflammatory Diseases
N/AAutoinflammatory diseases (AID) are caused by innate immunity dysregulation...
Location
Service de Médecine Interne
Epidemiological Data on Mast Cell Pathologies in France
N/AMast cell disorders constitute a heterogeneous group of diseases, including...
Location
CHU AMIENS site sud
Analysis of the Role of IgE Proteoforms in Health and Disease
N/AThe goal of this observational study is to evaluate the role of IgE proteof...
Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis
N/ASystemic Mastocytosis is a rare and complex disease caused by accumulation ...
Status
Active Not Recruiting
Location
Karolinska Institutet
Myeloproliferative Neoplasms (MPNs) Patient Registry
N/AThe mandate of this MPN registry is to collect clinical information, includ...
Location
Princess Margaret Cancer Centre
Angioedema Biomarker Research Study
N/AThis clinical trial aims to evaluate and compare novel and commercially ava...
Location
Institute for Asthma and Allergy Clinical Research
Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia
N/AThe observational study aimed at evaluating the incidence of systemic masto...
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
PHASE2RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxy...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office